BioSpace News Archive

A handful of companies, together account for a large share in the global non-invasive fat reduction market, thereby making it consolidated.

Cambridge Allergy Ltd announced that its manufacturing facility outside of Portsmouth, United Kingdom was approved by the MHRA, the Medicines and Healthcare products Regulatory Agency, to manufacture its proprietary peanut allergy treatment under current Good Manufacturing Practices standards.

MANA’s next-generation EDIFY™ platform expands the potential of cell therapies with off-the-shelf allogeneic approaches to liquid and solid tumors

Record quarterly revenue driven by strength in COVID-19 testing and growth in lung diagnostic testing

TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 39 th Annual J.P. Morgan Healthcare Conference, being held virtually. The presentation is scheduled to take place on Tuesday, January 12, 2021 at 2:00 PM ET. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Comp